EU TRANSPARENCY REGISTER · 940251520152-08 · Switzerland

BGP Products Operations GmbH – a Viatris Company

Viatris

Category

Companies & groups

Country

Switzerland

Steinhausen

Entity form

GmbH

Stated objectives

Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, leveraging the strengths of both companies and approximately 38,000 colleagues worldwide. As one of the top three pharmaceutical companies in…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2016-01-04

Last updated

2025-08-27

Other Companies & groups in Switzerland

Other registered organisations in Switzerland

Frequently asked questions

What is this organisation?
BGP Products Operations GmbH – a Viatris Company (Viatris) is an interest representative listed in the EU Joint Transparency Register under ID 940251520152-08. Entity form: GmbH.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in Switzerland, Steinhausen.
What are its stated goals?
As declared by the registrant: Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, leveraging the strengths of both companies and approximately 38,000 colleagues worldwide. As one of the top three pharmaceutical companies in…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 940251520152-08.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-02 · Commission Reuse Decision 2011/833/EU